AU2351197A - Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith - Google Patents

Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Info

Publication number
AU2351197A
AU2351197A AU23511/97A AU2351197A AU2351197A AU 2351197 A AU2351197 A AU 2351197A AU 23511/97 A AU23511/97 A AU 23511/97A AU 2351197 A AU2351197 A AU 2351197A AU 2351197 A AU2351197 A AU 2351197A
Authority
AU
Australia
Prior art keywords
liver disorders
prevention
treatment
associated therewith
complications associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23511/97A
Other languages
English (en)
Inventor
Martin Bickel
Holger Heitsch
Max Hropot
Adalbert Wagner
Klaus Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU2351197A publication Critical patent/AU2351197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU23511/97A 1996-05-22 1997-05-20 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith Abandoned AU2351197A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE19620509 1996-05-22
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19632042 1996-08-08
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303 1996-09-25
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
AU2351197A true AU2351197A (en) 1997-11-27

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23511/97A Abandoned AU2351197A (en) 1996-05-22 1997-05-20 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Country Status (23)

Country Link
US (1) US5786365A (https=)
EP (2) EP0808627A2 (https=)
JP (1) JP4034849B2 (https=)
CN (1) CN1176102A (https=)
AT (1) ATE189389T1 (https=)
AU (1) AU2351197A (https=)
BR (1) BR9703367A (https=)
CA (1) CA2205780A1 (https=)
CZ (1) CZ154697A3 (https=)
DE (1) DE59701078D1 (https=)
DK (1) DK0808628T3 (https=)
ES (1) ES2144291T3 (https=)
GR (1) GR3033048T3 (https=)
HR (1) HRP970278A2 (https=)
HU (1) HUP9700913A1 (https=)
ID (1) ID18447A (https=)
IL (1) IL120862A0 (https=)
NO (1) NO972311L (https=)
PL (1) PL320134A1 (https=)
PT (1) PT808628E (https=)
SI (1) SI0808628T1 (https=)
SK (1) SK63097A3 (https=)
TR (1) TR199700392A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740543B2 (en) * 1996-12-20 2001-11-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg New aqueous medicament preparations for the production of propellent gas-free aerosols

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19712960A1 (de) 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
AU1521500A (en) 1998-11-10 2000-05-29 W. Robert Colman Inhibition of angiogenesis by peptide analogs of high molecular weight kininogendomain
JP2002529474A (ja) * 1998-11-10 2002-09-10 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 高分子量キニノゲン及びそのペプチド類似体による血管形成の抑制
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
AU2004298486A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
US20060264415A1 (en) * 2005-04-01 2006-11-23 Methylgene Inc. Inhibitors of histone deacetylase
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
AU2011276482A1 (en) 2010-06-29 2013-02-21 Jennifer Digrazia Wound and bandage protection system and method
US12427067B2 (en) 2010-06-29 2025-09-30 Jennifer DiGrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
WO1996004251A1 (en) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740543B2 (en) * 1996-12-20 2001-11-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg New aqueous medicament preparations for the production of propellent gas-free aerosols

Also Published As

Publication number Publication date
EP0808628B1 (de) 2000-02-02
GR3033048T3 (en) 2000-08-31
CN1176102A (zh) 1998-03-18
JP4034849B2 (ja) 2008-01-16
HUP9700913A1 (hu) 1999-09-28
ES2144291T3 (es) 2000-06-01
EP0808628A3 (de) 1998-01-14
CA2205780A1 (en) 1997-11-22
SI0808628T1 (en) 2000-04-30
JPH1045624A (ja) 1998-02-17
MX9703725A (es) 1997-11-29
ID18447A (id) 1998-04-09
BR9703367A (pt) 1998-09-15
IL120862A0 (en) 1997-09-30
EP0808628A2 (de) 1997-11-26
ATE189389T1 (de) 2000-02-15
NO972311D0 (no) 1997-05-21
DK0808628T3 (da) 2000-06-26
EP0808627A2 (de) 1997-11-26
DE59701078D1 (de) 2000-03-09
NO972311L (no) 1997-11-24
SK63097A3 (en) 1997-12-10
HRP970278A2 (en) 1998-04-30
PL320134A1 (en) 1997-11-24
HU9700913D0 (en) 1997-07-28
TR199700392A2 (xx) 1997-12-21
PT808628E (pt) 2000-05-31
CZ154697A3 (en) 1997-12-17
US5786365A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
AU2351197A (en) Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith
AU6500298A (en) Derivatives of azetidine and pyrrolidine
EP0454501A3 (en) Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
DK0620215T3 (da) 1H-indol-3-acetamidderivater som sPLA2-inhibitorer
NO931401L (no) Steroidderivater for behandling av prostatahypertrofi, samt fremstilling og anvendelse derav
AU2215588A (en) Substituted cycloalkanols
IL145633A0 (en) Pharmaceutical compounds
CA2321188A1 (en) Derivatives of azetidine and pyrrolidine
ATE284692T1 (de) Verwendung von nicht-peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimerischen krankheit
EP1094055A4 (en) NEW VINYLBENZENE DERIVATIVES
DK0838223T3 (da) Hjerneødeminhibitor
IL88740A0 (en) Compositions for the inhibition of viruses
NO975903D0 (no) N-benzylpiperazin-forbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske blandinger
ES2188260T3 (es) 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos.
GB8706662D0 (en) Anti-arrhythmia agents
DE60027204D1 (en) Benzamidinderivate
PL329885A1 (en) Derivatives of polyhydroxyphenol and agents containing them for use in prophylactics and treatment of bone and cartilage diseases
ATE71364T1 (de) Fluor enthaltende vitamin-d2-derivate.